## Abstract The widespread acceptance of photodynamic therapy (PDT), a potential adjuvant brain tumor therapy under clinical evaluation since 1980, has been partially restrained by its potential toxicity toward normal brain tissue. This study examined PDTโproduced injury of normal rat brain as a fu
Toxicity of photodynamic therapy with photofrin in the normal rat brain
โ Scribed by Ying Ji; Dr. Stephen K. Powers; J. Tony Brown; Diana Walstad; Lloyd Maliner
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 1007 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0196-8092
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Toxicity studies for intraperitoneal photodynamic therapy (IPPDT) were performed in Wag/RijA rats, using specially designed light delivery blocks for proper light distribution and light dosimetry. A recently developed photosensitizer mesotetrahydroxyphenylchlorin (mTHPC), excited at 652
## Background and Objective : The reactive oxygen mechanisms associated with cell damage after photodynamic therapy (PDT) may be exploited to enhance tumor destruction. Pharmacological reduction of glutathione (GSH), an inhibitor of reactive oxygen species, can be induced by administration of buth
## Background and objective: Liposomes as photosensitizer carriers may enhance the photodynamic effect on tumors. ## Study design/materials and methods: To test this hypothesis, we treated u87 human glioma in rat brain with photodynamic therapy (pdt) using photofrin encapsulated in a liposome car
Using normal rat liver we investigated the depth of necrosis induced by photodynamic therapy when different light doses and photosensitizer (Photogemยฎ) concentrations. All experiments were done with a fluence rate of 250 mW/cm^2^. Photosensitizer concentration was varied from 1.0, 1.5, 2.0, and 5.0